Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 581 of 6351
-
New pill combo aims to keep blood cancer at bay
Disease control Recruiting nowThis is a phase 2 study to investigate the efficacy and safety of DZD8586 in combination in participants with CLL/SLL. This study consists of two parts: Part A is the safety lead-in phase, and Part B is the dose expansion phase.
Phase 2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug duo takes on tough prostate cancers
Disease control Recruiting nowThis study is a prospective, single arm II clinical trial. The main objective of the study is to evaluate the efficacy and safety of the combination of Sacituzumab Tirumotecan (SKB264) and Tagitanlimab (KL-A167) in the treatment of AVPC (aggressive variant prostate cancer) and NE…
Phase 2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:44 UTC
-
New drug duo targets tough lung cancer mutation
Disease control Recruiting nowThis is a multicenter, open-label phase 2 study that will enroll KRASG12C mutated patients with locally advanced or metastatic NSCLC, receiving treatment (ABSK043 in combination with Glecirasib) in a 21-day combination cycle.
Phase 2 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis study is an investigation to evaluate the safety/tolerability, pharmacokinetics (PK), and efficacy of GFH276 as a single agent in patients with advanced solid tumors harboring RAS mutations. The primary objectives of the Phase I study are to assess the safety/tolerability, …
Phase 1/2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a milk ingredient boost brain health in starving kids?
Disease control Recruiting nowThe goal of this clinical trial is to test the use of milk fat globule membrane (MFGM) in ready-to-use therapeutic food (RUTF) in children with severe acute malnutrition in Sierra Leone. The main questions it aims to answer are: * Will the inclusion of MFGM in RUTF for 6-59-mont…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a new drug clear mucus plugs in COPD lungs? trial launches.
Disease control Recruiting nowLPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is to assess the effect of dupilumab compared with placebo on airway inflammation, resistance, and remodeling including mucu…
Phase 4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New combo therapy could shrink rare lung tumors
Disease control Recruiting nowThe goal of this clinical trial is to investigate if chemotherapy works with surufatinib to treat pulmonary neuroendocrine tumors. It will also learn about the safety of this combination regimen. The main questions it aims to answer are: Does chemotherapy combined with surufatin…
Phase 2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Engineered immune cells take on childhood cancer
Disease control Recruiting nowBackground: Rhabdomyosarcoma (RMS) is a cancer of soft tissues. It is the most common soft tissue sarcoma seen in children. RMS cancer cells have a protein called FGFR4 on their surface. Researchers want to try a new kind of treatment for RMS: They will collect a person s own T …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a single bone screw save ankles from arthritis?
Disease control OngoingBackground and Rationale: Injury to the tibiofibular syndesmosis in ankle fractures is a major prognostic factor for the development of post-traumatic osteoarthritis. The syndesmosis is frequently involved when posterior tibial marginal fragments are fractured. Intraoperative st…
Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Veterans with PTSD to test cannabis as a treatment for suicidal thoughts
Symptom relief Recruiting nowThis study is a randomized, controlled clinical trial to examine the therapeutic potential of cannabinoids for treating veterans with PTSD and suicidal ideation.
Phase 1/2 • Sponsor: Wayne State University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can AI make acupuncture more precise for allergy relief?
Disease control CompletedThis study evaluated a new way to perform acupuncture at a deep point called the Xinwu point (sphenopalatine ganglion) for allergic rhinitis (hay fever-like nasal allergy). The point is hard to reach with the usual blind needling method. Artificial intelligence (AI) with real-tim…
Sponsor: Daxing Teaching Hospital, Capital Medical University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Pee test could replace painful bladder scopes for cancer patients
Diagnosis Recruiting nowNon-muscle-invasive bladder cancer (NMIBC) is usually treated with surgery to remove the tumor (transurethral resection of bladder tumor, or TURBT), often followed by bladder-instilled medications to reduce the chance of the cancer coming back. Even with this treatment, high-grad…
Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New triple therapy aims to shrink rectal tumors and avoid surgery
Disease control Not yet recruitingThis is a multicenter, prospective, phase II study evaluating total neoadjuvant therapy (TNT) consisting of short-course radiotherapy (SCRT; 5×5 Gy) followed by QL1706 (a bifunctional MabPair antibody targeting PD-1 and CTLA-4, code name only) plus mFOLFOX6 chemotherapy in patien…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 18:06 UTC
-
Hospital Gun-Safety talks could save young lives
Prevention Recruiting nowFirearm injuries are the leading cause of death for American youth. While most of these deaths are homicides, approximately one third are suicides and 5% are unintentional shootings where a child gains access to an unsecured firearm and unintentionally pulls the trigger injuring …
Sponsor: Vanderbilt University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo aims to shrink lung tumors before surgery in targeted trial
Disease control Not yet recruitingThis study aim to evaluate the efficacy and safety of Bozitinib combined with chemotherapy as radical treatment for stage IIA-IIIC MET-altered non-small cell lung cancer
Phase 2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 26, 2026 13:39 UTC
-
Kids' PTSD treatment uses imagination to rewrite traumatic memories
Symptom relief Recruiting nowThis study is testing a new version of a treatment called the Reconsolidation of Traumatic Memories Protocol for Children (RTM-C Protocol). The RTM Protocol™ is already proven to help adults with post-traumatic stress disorder (PTSD) by reducing distressing memories, flashbacks, …
Sponsor: Viktoriia Gorbunova • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New drug targets Gene-Amplified breast cancers in early trial
Disease control Not yet recruitingThis study is an open-label, multicenter Phase IIa trial to evaluate the efficacy and safety of SC-101 monotherapy in patients with locally advanced or metastatic malignant tumors who are positive for NECTIN4 gene amplification.
Phase 2 • Sponsor: Tianjin ConjuStar Biologics Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:32 UTC
-
Could cilostazol beat aspirin at preventing strokes?
Disease control Not yet recruitingThis study is designed to evaluate whether cilostazol, an antiplatelet medication, is more effective and safer than aspirin or clopidogrel in preventing recurrent strokes and slowing disease progression in patients with cerebral small vessel disease (CSVD). Cerebral small vessel…
Phase 4 • Sponsor: First Affiliated Hospital of Chengdu Medical College • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a simple Under-the-Tongue spray protect kidneys?
Disease control Recruiting nowThis study investigates the safety and efficacy of ACE Reno, an oral transmucosal solution containing standardized bioactive peptides and amino acids, in patients with nephropathy of various etiologies and stages. The trial evaluates whether 12 weeks of ACE Reno (1 mL sublinguall…
Phase 4 • Sponsor: Ace Cells Lab Limited • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug duo targets tough pancreatic cancer in phase 2 trial
Disease control Recruiting nowThis is an open-label, multi-center phase II clinical study consisting of two parts: Part I: To evaluate the safety and efficacy of AK130 combined with AK112 in advanced pancreatic cancer. Part II: To evaluate the safety and efficacy of AK112, either as monotherapy or in combin…
Phase 2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC